These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12479561)

  • 41. Effect of rubella vaccination programme on serological status of young adults in United Kingdom.
    Clarke M; Schild GC; Boustred J; Seagroatt V; Pollock TM; Finlay SE; Barbara JA
    Lancet; 1979 Jun; 1(8128):1224-6. PubMed ID: 87687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
    Hyde TB; Kruszon-Moran D; McQuillan GM; Cossen C; Forghani B; Reef SE
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S146-50. PubMed ID: 16998774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in the distribution of rubella antibodies in women of childbearing age during the first eight years of a rubella vaccination programme.
    Hambling MH
    J Infect; 1980 Dec; 2(4):341-6. PubMed ID: 7185933
    [No Abstract]   [Full Text] [Related]  

  • 45. Rubella vaccination of unknowingly pregnant women: the São Paulo experience, 2001.
    Sato HK; Sanajotta AT; Moraes JC; Andrade JQ; Duarte G; Cervi MC; Curti SP; Pannuti CS; Milanez H; Pessoto M; Flannery B; Oselka GW;
    J Infect Dis; 2011 Sep; 204 Suppl 2():S737-44. PubMed ID: 21954275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002.
    da Silva e Sá GR; Camacho LA; Stavola MS; Lemos XR; Basílio de Oliveira CA; Siqueira MM
    J Infect Dis; 2011 Sep; 204 Suppl 2():S722-8. PubMed ID: 21954273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
    Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
    Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The 1984/85 rubella epidemic in Austria].
    Hofmann H; Kunz C; Popow-Kraupp T; Radda AC
    Wien Klin Wochenschr; 1986 Mar; 98(5):133-7. PubMed ID: 3962315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of congenital rubella and results of rubella vaccination in Australia.
    Menser MA; Hudson JR; Murphy AM; Upfold LJ
    Rev Infect Dis; 1985; 7 Suppl 1():S37-41. PubMed ID: 3890106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences.
    Majlessi F; Batebi A; Shariat M; Rahimi A; Azad TM
    East Mediterr Health J; 2008; 14(3):590-4. PubMed ID: 18720623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seroprevalence of rubella antibodies among antenatal patients in the Western Cape.
    Corcoran C; Hardie DR
    S Afr Med J; 2005 Sep; 95(9):688-90. PubMed ID: 16327929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is birth cohort 1985/9-1990/8 a susceptibility window for congenital rubella syndrome in Taiwan?
    Lin CL; Shih SF; Tsai PH; Liang AC
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):368-73. PubMed ID: 27343317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How useful is a history of rubella vaccination for determination of disease susceptibility? A cross-sectional study at a public funded health clinic in Malaysia.
    Cheong AT; Tong SF; Khoo EM
    BMC Fam Pract; 2013 Jan; 14():19. PubMed ID: 23368977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rubella Seropositivity in Pregnant Women After Vaccination Campaign in Brazil's Federal District.
    Nóbrega YKM; de Carvalho BC; Nitz N; Vital TE; Leite FB; Sequeira IJ; Moreira EE; de Andrade JKB; Gandolfi L; Pratesi R; Hecht MM
    Viral Immunol; 2017 Nov; 30(9):675-677. PubMed ID: 28972455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rubella seroprevalence among women aged 15-39 years in Morocco.
    Caidi H; Bloom S; Azilmaat M; Benjouad A; Reef S; El Aouad R
    East Mediterr Health J; 2009; 15(3):526-31. PubMed ID: 19731768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey.
    Aksit S; Egemen A; Ozacar T; Kurugol Z; Keskinoglu P; Tasbakan M; Caglayan S
    Pediatr Infect Dis J; 1999 Jul; 18(7):577-80. PubMed ID: 10440431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immune protection against rubella in a group of women in Latium].
    Fischetti M; Melino C; Venza F
    Clin Ter; 1991 Feb; 136(3):173-8. PubMed ID: 1827380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India.
    Vijayalakshmi P; Anuradha R; Prakash K; Narendran K; Ravindran M; Prajna L; Brown D; Robertson SE
    Bull World Health Organ; 2004 Apr; 82(4):259-64. PubMed ID: 15259254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.